APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Mullerian Hormone (AMH) Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-Mullerian Hormone (AMH) Test Market Analysis and Forecast 2026-2032

4 March 2026204 pages

Choose your research edition.

Industry ResearchAnti-Mullerian Hormone (AMH) Test Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Mullerian Hormone (AMH) Test Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Anti-Mullerian Hormone (AMH) Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Mullerian Hormone (AMH) Test Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Mullerian Hormone (AMH) Test Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Anti-Mullerian Hormone (AMH) Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Anti-Mullerian Hormone (AMH) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-Mullerian Hormone (AMH) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-Mullerian Hormone (AMH) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-Mullerian Hormone (AMH) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Anti-Mullerian Hormone (AMH) Test include Roche, Beckman Coulter, BioMérieux, Monash IVF, Bumrungrad International Hospital, CTK Biotech, Biotime, Boditech Med and CREATE Fertility, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Anti-Mullerian Hormone (AMH) Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-Mullerian Hormone (AMH) Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Anti-Mullerian Hormone (AMH) Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-Mullerian Hormone (AMH) Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-Mullerian Hormone (AMH) Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Anti-Mullerian Hormone (AMH) Test revenue, projected growth trends, production technology, application and end-user industry.

Anti-Mullerian Hormone (AMH) Test Segment by Company

Roche

Beckman Coulter

BioMérieux

Monash IVF

Bumrungrad International Hospital

CTK Biotech

Biotime

Boditech Med

CREATE Fertility

Repromed Fertility Specialists

Quest Health

Clinpath Pathology

Shenzhen YHLO Biotech

Guangzhou Kangrun Biotechnology

Guangzhou Wondfo Biotech

Beijing Savant Biotechnology

Anti-Mullerian Hormone (AMH) Test Segment by Type

Chemiluminescence Immunoassay

ELISA

Magnetic Particle Chemiluminescence

Flow Cytometry Fluorescence Luminescence

Other

Anti-Mullerian Hormone (AMH) Test Segment by Application

Assisted Reproduction

Polycystic Ovary Syndrome

Ovarian Cancer

Other

Anti-Mullerian Hormone (AMH) Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Mullerian Hormone (AMH) Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Mullerian Hormone (AMH) Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Mullerian Hormone (AMH) Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Anti-Mullerian Hormone (AMH) Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Anti-Mullerian Hormone (AMH) Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Mullerian Hormone (AMH) Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chemiluminescence Immunoassay Major Player Table 3. ELISA Major Player Table 4. Magnetic Particle Chemiluminescence Major Player Table 5. Flow Cytometry Fluorescence Luminescence Major Player Table 6. Other Major Player Table 7. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Assisted Reproduction Major Player Table 9. Polycystic Ovary Syndrome Major Player Table 10. Ovarian Cancer Major Player Table 11. Other Major Player Table 12. Anti-Mullerian Hormone (AMH) Test Industry Trends Table 13. Anti-Mullerian Hormone (AMH) Test Industry Drivers Table 14. Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges Table 15. Anti-Mullerian Hormone (AMH) Test Industry Restraints Table 16. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region (2021-2026) Table 19. Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region (2027-2032) Table 21. Global Anti-Mullerian Hormone (AMH) Test Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Players (2021-2026) Table 23. Global Anti-Mullerian Hormone (AMH) Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Anti-Mullerian Hormone (AMH) Test Key Players Headquarters & Area Served Table 25. Global Anti-Mullerian Hormone (AMH) Test Players, Product Type & Application Table 26. Global Anti-Mullerian Hormone (AMH) Test Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Anti-Mullerian Hormone (AMH) Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Anti-Mullerian Hormone (AMH) Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Type (2021-2026) Table 33. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Type (2027-2032) Table 34. Global Anti-Mullerian Hormone (AMH) Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2021-2026) Table 38. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2027-2032) Table 39. Roche Company Information Table 40. Roche Business Overview Table 41. Roche Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 43. Roche Recent Development Table 44. Beckman Coulter Company Information Table 45. Beckman Coulter Business Overview Table 46. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 48. Beckman Coulter Recent Development Table 49. BioMérieux Company Information Table 50. BioMérieux Business Overview Table 51. BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 53. BioMérieux Recent Development Table 54. Monash IVF Company Information Table 55. Monash IVF Business Overview Table 56. Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 58. Monash IVF Recent Development Table 59. Bumrungrad International Hospital Company Information Table 60. Bumrungrad International Hospital Business Overview Table 61. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 63. Bumrungrad International Hospital Recent Development Table 64. CTK Biotech Company Information Table 65. CTK Biotech Business Overview Table 66. CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 68. CTK Biotech Recent Development Table 69. Biotime Company Information Table 70. Biotime Business Overview Table 71. Biotime Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 73. Biotime Recent Development Table 74. Boditech Med Company Information Table 75. Boditech Med Business Overview Table 76. Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 78. Boditech Med Recent Development Table 79. CREATE Fertility Company Information Table 80. CREATE Fertility Business Overview Table 81. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 83. CREATE Fertility Recent Development Table 84. Repromed Fertility Specialists Company Information Table 85. Repromed Fertility Specialists Business Overview Table 86. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 88. Repromed Fertility Specialists Recent Development Table 89. Quest Health Company Information Table 90. Quest Health Business Overview Table 91. Quest Health Anti-Mullerian Hormone (AMH) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 93. Quest Health Recent Development Table 94. Clinpath Pathology Company Information Table 95. Clinpath Pathology Business Overview Table 96. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 98. Clinpath Pathology Recent Development Table 99. Shenzhen YHLO Biotech Company Information Table 100. Shenzhen YHLO Biotech Business Overview Table 101. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 103. Shenzhen YHLO Biotech Recent Development Table 104. Guangzhou Kangrun Biotechnology Company Information Table 105. Guangzhou Kangrun Biotechnology Business Overview Table 106. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 108. Guangzhou Kangrun Biotechnology Recent Development Table 109. Guangzhou Wondfo Biotech Company Information Table 110. Guangzhou Wondfo Biotech Business Overview Table 111. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 113. Guangzhou Wondfo Biotech Recent Development Table 114. Beijing Savant Biotechnology Company Information Table 115. Beijing Savant Biotechnology Business Overview Table 116. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio Table 118. Beijing Savant Biotechnology Recent Development Table 119. North America Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026) & (US$ Million) Table 122. North America Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032) & (US$ Million) Table 123. North America Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021-2026) & (US$ Million) Table 125. North America Anti-Mullerian Hormone (AMH) Test Revenue by Country (US$ Million) & (2027-2032) Table 126. Europe Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021-2026) & (US$ Million) Table 132. Europe Anti-Mullerian Hormone (AMH) Test Revenue by Country (US$ Million) & (2027-2032) Table 133. China Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026) & (US$ Million) Table 134. China Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032) & (US$ Million) Table 135. China Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026) & (US$ Million) Table 136. China Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Anti-Mullerian Hormone (AMH) Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Anti-Mullerian Hormone (AMH) Test Revenue by Region (US$ Million) & (2021-2026) Table 143. Asia Anti-Mullerian Hormone (AMH) Test Revenue by Region (US$ Million) & (2027-2032) Table 144. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026) & (US$ Million) Table 145. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032) & (US$ Million) Table 146. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026) & (US$ Million) Table 147. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032) & (US$ Million) Table 148. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021-2026) & (US$ Million) Table 150. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Country (US$ Million) & (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Anti-Mullerian Hormone (AMH) Test Image Figure 2. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Mullerian Hormone (AMH) Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chemiluminescence Immunoassay Image Figure 5. ELISA Image Figure 6. Magnetic Particle Chemiluminescence Image Figure 7. Flow Cytometry Fluorescence Luminescence Image Figure 8. Other Image Figure 9. Global Anti-Mullerian Hormone (AMH) Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Anti-Mullerian Hormone (AMH) Test Market Size Share 2021 VS 2025 VS 2032 Figure 11. Assisted Reproduction Image Figure 12. Polycystic Ovary Syndrome Image Figure 13. Ovarian Cancer Image Figure 14. Other Image Figure 15. Global Anti-Mullerian Hormone (AMH) Test Market Size (US$ Million) & (2021-2032) Figure 16. Global Anti-Mullerian Hormone (AMH) Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Anti-Mullerian Hormone (AMH) Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Anti-Mullerian Hormone (AMH) Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Type (2021-2032) Figure 23. Global Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2021-2032) Figure 26. North America Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032) Figure 28. North America Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032) Figure 29. North America Anti-Mullerian Hormone (AMH) Test Revenue Share by Country (2021-2032) Figure 30. United States Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032) Figure 35. Europe Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032) Figure 36. Europe Anti-Mullerian Hormone (AMH) Test Revenue Share by Country (2021-2032) Figure 37. Germany Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032) Figure 47. China Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032) Figure 48. Asia Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032) Figure 50. Asia Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032) Figure 51. Asia Anti-Mullerian Hormone (AMH) Test Revenue Share by Region (2021-2032) Figure 52. Japan Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032) Figure 60. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032) Figure 61. SAMEA Anti-Mullerian Hormone (AMH) Test Revenue Share by Country (2021-2032) Figure 62. Brazil Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Anti-Mullerian Hormone (AMH) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Chemiluminescence Immunoassay
  • ELISA
  • Magnetic Particle Chemiluminescence
  • Flow Cytometry Fluorescence Luminescence
  • Other
Applications
  • Assisted Reproduction
  • Polycystic Ovary Syndrome
  • Ovarian Cancer
  • Other
Companies covered
  • Roche
  • Beckman Coulter
  • BioMérieux
  • Monash IVF
  • Bumrungrad International Hospital
  • CTK Biotech
  • Biotime
  • Boditech Med
  • CREATE Fertility
  • Repromed Fertility Specialists
  • Quest Health
  • Clinpath Pathology
  • Shenzhen YHLO Biotech
  • Guangzhou Kangrun Biotechnology
  • Guangzhou Wondfo Biotech
  • Beijing Savant Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-Mullerian Hormone (AMH) Test Market by Type
  3. 1.2.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chemiluminescence Immunoassay
  5. 1.2.3 ELISA
  6. 1.2.4 Magnetic Particle Chemiluminescence
  7. 1.2.5 Flow Cytometry Fluorescence Luminescence
  8. 1.2.6 Other
  9. 1.3 Anti-Mullerian Hormone (AMH) Test Market by Application
  10. 1.3.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Assisted Reproduction
  12. 1.3.3 Polycystic Ovary Syndrome
  13. 1.3.4 Ovarian Cancer
  14. 1.3.5 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Anti-Mullerian Hormone (AMH) Test Market Dynamics
  1. 2.1 Anti-Mullerian Hormone (AMH) Test Industry Trends
  2. 2.2 Anti-Mullerian Hormone (AMH) Test Industry Drivers
  3. 2.3 Anti-Mullerian Hormone (AMH) Test Industry Opportunities and Challenges
  4. 2.4 Anti-Mullerian Hormone (AMH) Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Anti-Mullerian Hormone (AMH) Test Market Perspective (2021-2032)
  2. 3.2 Global Anti-Mullerian Hormone (AMH) Test Growth Trends by Region
  3. 3.2.1 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2021-2026)
  5. 3.2.3 Global Anti-Mullerian Hormone (AMH) Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Anti-Mullerian Hormone (AMH) Test Revenue by Players
  2. 4.1.1 Global Anti-Mullerian Hormone (AMH) Test Revenue by Players (2021-2026)
  3. 4.1.2 Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Anti-Mullerian Hormone (AMH) Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-Mullerian Hormone (AMH) Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Anti-Mullerian Hormone (AMH) Test Key Players Headquarters & Area Served
  7. 4.4 Global Anti-Mullerian Hormone (AMH) Test Players, Product Type & Application
  8. 4.5 Global Anti-Mullerian Hormone (AMH) Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Anti-Mullerian Hormone (AMH) Test Market CR5 and HHI
  11. 4.6.3 2025 Anti-Mullerian Hormone (AMH) Test Tier 1, Tier 2, and Tier 3
5 Anti-Mullerian Hormone (AMH) Test Market Size by Type
  1. 5.1 Global Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2032)
  3. 5.3 Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Type (2021-2032)
6 Anti-Mullerian Hormone (AMH) Test Market Size by Application
  1. 6.1 Global Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2032)
  3. 6.3 Global Anti-Mullerian Hormone (AMH) Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Roche
  2. 7.1.1 Roche Company Information
  3. 7.1.2 Roche Business Overview
  4. 7.1.3 Roche Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Roche Anti-Mullerian Hormone (AMH) Test Product Portfolio
  6. 7.1.5 Roche Recent Developments
  7. 7.2 Beckman Coulter
  8. 7.2.1 Beckman Coulter Company Information
  9. 7.2.2 Beckman Coulter Business Overview
  10. 7.2.3 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Beckman Coulter Anti-Mullerian Hormone (AMH) Test Product Portfolio
  12. 7.2.5 Beckman Coulter Recent Developments
  13. 7.3 BioMérieux
  14. 7.3.1 BioMérieux Company Information
  15. 7.3.2 BioMérieux Business Overview
  16. 7.3.3 BioMérieux Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BioMérieux Anti-Mullerian Hormone (AMH) Test Product Portfolio
  18. 7.3.5 BioMérieux Recent Developments
  19. 7.4 Monash IVF
  20. 7.4.1 Monash IVF Company Information
  21. 7.4.2 Monash IVF Business Overview
  22. 7.4.3 Monash IVF Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Monash IVF Anti-Mullerian Hormone (AMH) Test Product Portfolio
  24. 7.4.5 Monash IVF Recent Developments
  25. 7.5 Bumrungrad International Hospital
  26. 7.5.1 Bumrungrad International Hospital Company Information
  27. 7.5.2 Bumrungrad International Hospital Business Overview
  28. 7.5.3 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bumrungrad International Hospital Anti-Mullerian Hormone (AMH) Test Product Portfolio
  30. 7.5.5 Bumrungrad International Hospital Recent Developments
  31. 7.6 CTK Biotech
  32. 7.6.1 CTK Biotech Company Information
  33. 7.6.2 CTK Biotech Business Overview
  34. 7.6.3 CTK Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CTK Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  36. 7.6.5 CTK Biotech Recent Developments
  37. 7.7 Biotime
  38. 7.7.1 Biotime Company Information
  39. 7.7.2 Biotime Business Overview
  40. 7.7.3 Biotime Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Biotime Anti-Mullerian Hormone (AMH) Test Product Portfolio
  42. 7.7.5 Biotime Recent Developments
  43. 7.8 Boditech Med
  44. 7.8.1 Boditech Med Company Information
  45. 7.8.2 Boditech Med Business Overview
  46. 7.8.3 Boditech Med Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boditech Med Anti-Mullerian Hormone (AMH) Test Product Portfolio
  48. 7.8.5 Boditech Med Recent Developments
  49. 7.9 CREATE Fertility
  50. 7.9.1 CREATE Fertility Company Information
  51. 7.9.2 CREATE Fertility Business Overview
  52. 7.9.3 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CREATE Fertility Anti-Mullerian Hormone (AMH) Test Product Portfolio
  54. 7.9.5 CREATE Fertility Recent Developments
  55. 7.10 Repromed Fertility Specialists
  56. 7.10.1 Repromed Fertility Specialists Company Information
  57. 7.10.2 Repromed Fertility Specialists Business Overview
  58. 7.10.3 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Repromed Fertility Specialists Anti-Mullerian Hormone (AMH) Test Product Portfolio
  60. 7.10.5 Repromed Fertility Specialists Recent Developments
  61. 7.11 Quest Health
  62. 7.11.1 Quest Health Company Information
  63. 7.11.2 Quest Health Business Overview
  64. 7.11.3 Quest Health Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Quest Health Anti-Mullerian Hormone (AMH) Test Product Portfolio
  66. 7.11.5 Quest Health Recent Developments
  67. 7.12 Clinpath Pathology
  68. 7.12.1 Clinpath Pathology Company Information
  69. 7.12.2 Clinpath Pathology Business Overview
  70. 7.12.3 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Clinpath Pathology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  72. 7.12.5 Clinpath Pathology Recent Developments
  73. 7.13 Shenzhen YHLO Biotech
  74. 7.13.1 Shenzhen YHLO Biotech Company Information
  75. 7.13.2 Shenzhen YHLO Biotech Business Overview
  76. 7.13.3 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Shenzhen YHLO Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  78. 7.13.5 Shenzhen YHLO Biotech Recent Developments
  79. 7.14 Guangzhou Kangrun Biotechnology
  80. 7.14.1 Guangzhou Kangrun Biotechnology Company Information
  81. 7.14.2 Guangzhou Kangrun Biotechnology Business Overview
  82. 7.14.3 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Guangzhou Kangrun Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  84. 7.14.5 Guangzhou Kangrun Biotechnology Recent Developments
  85. 7.15 Guangzhou Wondfo Biotech
  86. 7.15.1 Guangzhou Wondfo Biotech Company Information
  87. 7.15.2 Guangzhou Wondfo Biotech Business Overview
  88. 7.15.3 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Guangzhou Wondfo Biotech Anti-Mullerian Hormone (AMH) Test Product Portfolio
  90. 7.15.5 Guangzhou Wondfo Biotech Recent Developments
  91. 7.16 Beijing Savant Biotechnology
  92. 7.16.1 Beijing Savant Biotechnology Company Information
  93. 7.16.2 Beijing Savant Biotechnology Business Overview
  94. 7.16.3 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Beijing Savant Biotechnology Anti-Mullerian Hormone (AMH) Test Product Portfolio
  96. 7.16.5 Beijing Savant Biotechnology Recent Developments
8 North America
  1. 8.1 North America Anti-Mullerian Hormone (AMH) Test Revenue (2021-2032)
  2. 8.2 North America Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2032)
  3. 8.2.1 North America Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026)
  4. 8.2.2 North America Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032)
  5. 8.3 North America Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032)
  6. 8.4 North America Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2032)
  7. 8.4.1 North America Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026)
  8. 8.4.2 North America Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032)
  9. 8.5 North America Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032)
  10. 8.6 North America Anti-Mullerian Hormone (AMH) Test Revenue by Country
  11. 8.6.1 North America Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021-2026)
  13. 8.6.3 North America Anti-Mullerian Hormone (AMH) Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Anti-Mullerian Hormone (AMH) Test Revenue (2021-2032)
  2. 9.2 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032)
  5. 9.3 Europe Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032)
  9. 9.5 Europe Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Country
  11. 9.6.1 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe Anti-Mullerian Hormone (AMH) Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Anti-Mullerian Hormone (AMH) Test Revenue (2021-2032)
  2. 10.2 China Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2032)
  3. 10.2.1 China Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026)
  4. 10.2.2 China Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032)
  5. 10.3 China Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032)
  6. 10.4 China Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2032)
  7. 10.4.1 China Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026)
  8. 10.4.2 China Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032)
  9. 10.5 China Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-Mullerian Hormone (AMH) Test Revenue (2021-2032)
  2. 11.2 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032)
  5. 11.3 Asia Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032)
  9. 11.5 Asia Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Country
  11. 11.6.1 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia Anti-Mullerian Hormone (AMH) Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue (2021-2032)
  2. 12.2 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Country
  11. 12.6.1 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Anti-Mullerian Hormone (AMH) Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst